Successfully navigating this landscape requires legal advisors with deep sector knowledge and a commitment to staying across changes as they occur, and practical expertise. Bell Gully has extensive experience advising government agencies, healthcare providers, and pharmaceutical companies. We also have a long history of working with Pharmac, and other key entities on procurement, funding, and regulatory matters, helping clients manage commercial arrangements, legislative requirements, and sector-wide reforms.
We provide specialist advice on the regulatory framework applying in New Zealand including the Medicines Act and the Pae Ora (Healthy Futures) Act. We also advise on regulatory compliance, competition law, and privacy obligations under the Health Information Privacy Code, and have advised clients on the introduction and subsequent repeal of the Therapeutic Products Act. Our work also includes assisting clients with service provision contracts, pricing and reimbursement strategies, and engagement with regulators on policy and legislative developments.
Our understanding of the sector includes a broad team of experts across the firm and our work in this sector includes advising on commercial transactions, joint ventures, construction and development projects, as well as financing, taxation, and employment and matters that shape the healthcare sector. Our multi-disciplinary expertise ensures clients receive practical, commercially focused advice, enabling them to manage risk, meet regulatory obligations, and operate effectively in an evolving market.
With a thorough understanding of New Zealand's regulatory regime, Bell Gully is well-equipped to help clients navigate the sector's complexities. We provide clear, pragmatic advice to help clients navigate challenges, adapt to change, and capitalise on emerging opportunities.
